参考文献/References:
[1] Maradit KH,Crowson CS,Nicola PJ,et al.Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis:a population-based cohort study[J].Arthritis and Rheumatism,2005,52(2):402-411.
[2] Solomon DH,Goodson NJ,Katz JN,et al.Patterns of cardiovascular risk in rheumatoid arthritis[J].Annals of the Rheumatic Diseases,2006,65(12):1608-1612.
[3] Anyfanti P,Triantafyllou A,Gkaliagkousi E,et al.Retinal vessel morphology in rheumatoid arthritis:association with systemic inflammation,subclinical atherosclerosis,and cardiovascular risk[J].Microcirculation,2017,24(8):4451-4458.
[4] Engler A,Niederer F,Klein K,et al.SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts[J].Journal of Molecular Medicine(Berlin,Germany),2014,92(7):757-767.
[5] Chen Y,Dawes PT,Packham JC,et al.Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis[J].The Journal of Rheumatology,2011,38(5):802-809.
[6] Lahiri M,Luben RN,Morgan C,et al.Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis(results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register-the EPIC-2-NOAR Study)[J].Annals of the Rheumatic Diseases,2014,73(1):219-226.
[7] Robertson J,Peters MJ,McInnes IB,et al.Changes in lipid levels with inflammation and therapy in RA:a maturing paradigm[J].Nature Reviews Rheumatology,2013,9(9):513-523.
[8] Giles JT,Wasko MCM,Chung CP,et al.Exploring the lipid paradox theory in rheumatoid arthritis:associations of low circulating low-density lipoprotein concentration with subclinical coronary atherosclerosis[J].Arthritis & Rheumatology(Hoboken,NJ),2019,71(9):1426-1436.
[9] Burggraaf B,Stoep DF,Vries MA,et al.Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome[J].Atherosclerosis,2018,271:84-91.
[10] Taverner D,Vallvé JC,Ferre R,et al.Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients:sex-specific associations and differential effects of disease activity and age[J].PloS One,2018,13(3):e193690.
[11] Dehghan P,Rajaei A,Moeineddin R,et al.Prevalence of atherosclerosis in patients with inactive rheumatoid arthritis[J].Clinical Rheumatology,2015,34(8):1363-1366.
[12] Dalbeni A,Giollo A,Tagetti A,et al.Traditional cardiovascular risk factors or inflammation:which factors accelerate atherosclerosis in arthritis patients[J].International Journal of Cardiology,2017,236:488-492.
[13] 孙芳芳,张 静,范秀风.类风湿关节炎合并心血管损伤危险因素研究[J].陕西医学杂志,2019,48(10):1305-1309.
[14] El-Barbary AM,Kassem EM,El-Sergany MAS,et al.Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide[J].The Journal of Rheumatology,2011,38(5):828-834.
[15] Vazquez-Del M,Nuez-Atahualpa L,Figueroa-Sanchez M,et al.Serum levels of anticyclic citrullinated peptide antibodies,interleukin-6,tumor necrosis factor-α,and C-reactive protein are associated with increased carotid intima-media thickness:a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors[J].Biomed Research International,2015,2015:342649.
[16] Shi J,Stadt LA,Levarht EWN,et al.Anti-carbamylated protein(anti-CarP)antibodies precede the onset of rheumatoid arthritis[J].Annals of the Rheumatic Diseases,2014,73(4):780-783.
[17] Spinelli FR,Pecani A,Ciciarello F,et al.Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients[J].BMC Musculoskeletal Disorders,2017,18(1):214.
[18] Br E,Gm T,Dr A,et al.Increased cardiovascular risk in rheumatoid arthritis:mechanisms and implications[J].BMJ(Clinical Researched),2018,361:1036.
[19] Shen J,Shang Q,Wong CK,et al.IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis:a prospective study[J].Seminars in Arthritis and Rheumatism,2015,45(1):18-27.
[20] Li C,Mu R,Guo J,et al.Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis[J].Arthritis Research & Therapy,2014,16(2):105.
[21] López-Mejías R,Genre F,Remuzgo-Martínez S,et al.Protective role of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients[J].PloS One,2015,10(11):e143153.
[22] Pieper J,Johansson S,Snir O,et al.Peripheral and site-specific CD4+CD28(null)T cells from rheumatoid arthritis patients show distinct characteristics[J].Scandinavian Journal of Immunology,2014,79(2):149-155.
[23] Jellinger PS,Smith DA,Mehta AE,et al.American association of clinical endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis[J].Endocrine Practice:Official Journal of The American College of Endocrinology And The American Association of Clinical Endocrinologists,2012,18(1):1-78.
[24] Dergren A,Karp K,Bengtsson C,et al.Is lipoprotein-associated phospholipase a2 a link between inflammation and subclinical atherosclerosis in rheumatoid arthritis[J].Bio Med Research International,2015,2015:673018.
[25] Dessein PH,Tsang L,Norton GR,et al.Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis[J].PloS One,2014,9(3):e92739.
[26] Dimitroulas T,Hodson J,Sandoo A,et al.Symmetric dimethylarginine(SDMA)serum levels in rheumatoid arthritis:correlations with insulin resistance and disease activity scores[J].Amino Acids,2015,47(9):1995-2004.
[27] Sandoo A,Dimitroulas T,Hodson J,et al.Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis:a 6 year follow-up study[J].Rheumatology(Oxford,England),2015,54(7):1145-1152.
[28] Klimek E,Skalska A,Kwasny-Krochin B,et al.Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration[J].Mediators of Inflammation,2014,2014:681635.
[29] Dimitroulas T,Hodson J,Sandoo A,et al.Endothelial injury in rheumatoid arthritis:a crosstalk between dimethylarginines and systemic inflammation[J].Arthritis Research & Therapy,2017,19(1):32.
[30] Oláh C,Kardos Z,Sepsi M,et al.Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis[J].Arthritis Research & Therapy,2017,19(1):213.
相似文献/References:
[1]卢北玲,史剑飞,彭 晶,等.CRP、RF及ASO检测在类风湿关节炎合并肺间质纤维化诊断中的价值[J].陕西医学杂志,2019,(6):803.
[2]孙芳芳,张 静△,范秀风.类风湿关节炎合并心血管损伤危险因素研究*[J].陕西医学杂志,2019,(10):1305.
[3]王 颖,白 琳,张 洁,等.抑制炎性细胞因子与类风湿关节炎合并急性心肌梗死患者颈动脉斑块相关性研究*[J].陕西医学杂志,2019,(12):1679.
[4]刘玉珊.老年动脉粥样硬化性心肌梗死患者血清胱抑素C水平与血管内皮细胞损伤相关性研究*[J].陕西医学杂志,2020,49(4):431.
LIU Yushan..Relationship between serum cystatin C level and vascular endothelial cell injury in elderly patients with atherosclerotic myocardial infarction[J].,2020,49(11):431.
[5]刘昌莲,贺冬冬,李晓明,等.艾拉莫德治疗类风湿关节炎疗效及对患者免疫炎症因子水平和骨代谢指标的影响*[J].陕西医学杂志,2020,49(5):603.
LIU Changlian,HE Dongdong,LI Xiaoming,et al.Clinical efficacy of Iguratimod in the treatment of rheumatoid arthritis and its effect on the levels of immune inflammatory factors and the indexes of bone metabolism[J].,2020,49(11):603.
[6]刘子歌,刘 洋,宋国瑞,等.泡沫细胞在动脉粥样硬化形成过程中的作用研究进展*[J].陕西医学杂志,2020,49(10):1363.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.043]
LIU Zige,LIU Yang,SONG Guorui,et al.Research progress of foam cell in atherogenesis[J].,2020,49(11):1363.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.043]
[7]李长超,柴艳梅,刘 丹,等.类风湿关节炎患者血清IL-13水平表达及对外周血单个核细胞中Th17细胞亚群分化的影响[J].陕西医学杂志,2021,50(2):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
LI Changchao,CHAI Yanmei,LIU Dan,et al.Expression of serum IL-13 in patients with rheumatoid arthritis and its effect on differentiation of Th17 cell subsets in PBMC[J].,2021,50(11):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
[8]吴皓宇,曹怿玮,汪玲果,等.血管生成素-2促进内皮细胞基质金属蛋白酶-2表达实验研究[J].陕西医学杂志,2021,50(10):1183.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.002]
WU Haoyu,CAO Yiwei,WANG Lingguo,et al.Experimental study of angiopoietin-2 promoting the expression of matrix metalloproteinase-2 in endothelial cells[J].,2021,50(11):1183.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.002]
[9]安 新,冯 超,高利常.类风湿关节炎患者血清白细胞介素-32、白细胞介素-17和白细胞介素-10表达水平及临床意义[J].陕西医学杂志,2021,50(12):1585.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.030]
AN Xin,FENG Chao,GAO Lichang.Expression levels of serum interleukin-32,interleukin-17 and interleukin-10 in patients with rheumatoid arthritis and their clinical significance[J].,2021,50(11):1585.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.030]
[10]杨 婧,何家锐,孙红兵,等.沙利度胺对类风湿关节炎滑膜细胞及外周血单个核细胞分泌肿瘤坏死因子-α和血管内皮生长因子的影响及机制研究[J].陕西医学杂志,2022,51(12):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
YANG Jing,HE Jiarui,SUN Hongbing,et al.Effects of thalidomide on secretion of TNF-α and VEGF in fibroblast-like synoviocytes and peripheral blood mononuclear cells in patients with rheumatoid arthritis and its mechanism[J].,2022,51(11):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]